Medscape Conference Coverage, based on selected sessions at:

EAS 2008: The 77th European Atherosclerosis Society Congress

April 26 - 29, 2008; Istanbul, Turkey

This activity is not sanctioned by, nor a part of, the European Atherosclerosis Society.

Featured Coverage

  • New Approaches for Treating Atherosclerosis

    Treating dyslipidemia "beyond statins" -- the latest reports from the 2008 EAS conference concern ADAGIO-Lipids, apoC-III, and a new class of drugs for increasing HDL cholesterol.
  • Predicting Risk for Cardiovascular Events

    Calculating cardiovascular disease risk -- how to do it? Coronary artery calcification scores? Intima media thickness? apoC-III? Recent results with each of these show promise.

Conference News


The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European Atherosclerosis Society. These materials and the related activity are not sanctioned by the European Atherosclerosis Society or the commercial supporter of the conference and do not constitute an official part of that conference.